STICHTING HUBRECHT ORGANOID TECHNOLOGY - 
Ranking results:
Past rankings:
| 2020 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
| 2018 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
Ranking timeline:
Project Participation Performance(2018-01-01 - 2025-12-31 ):
Total Project Funding:
Funding per Partner:
Projects:
Leadership:
Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*
Summary:
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2023 | 0 | 3.763.200 | 0 | 1 | ||
| 2021 | 0 | 7.057.980 | 374.660 | 1 | ||
| 2020 | 0 | 4.998.688 | 679.464 | 1 | ||
| 2018 | 0 | 6.701.365 | 1.088.050 | 1 | ||
Networking:
Partners:
Constancy:
Total number of partners: 66
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 66
Frequent / Rare Partner Ratio: 0
Project overview:
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2023-01-01 | From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network | Maxima Butterfly | participant | 3.763.200 | 36 |
| 2021-07-01 | Building a reproducible single-cell experimental workflow to capture tumour drug persistence | PERSIST-SEQ | participant | 7.057.980 | 16 |
| 2020-01-01 | HCA|Organoid: Pilot action to establish a multi-tissue human organoid platform within the Human Cell Atlas as a booster of future disease-centric, mechanistic, and translational research | HCA Organoid | participant | 4.998.688 | 8 |
| 2018-01-01 | Personalised Treatment For Cystic Fibrosis Patients With Ultra-rare CFTR Mutations (and beyond) | HIT-CF | participant | 6.701.365 | 10 |